Exercise plus protein shakes for people with pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies whether a supervised resistance exercise program combined with protein supplementation can help people with non-metastatic pancreatic cancer during chemotherapy. It may improve strength and how well you tolerate treatment, with safety monitoring throughout.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has not spread to other parts of the body (no metastases).
- You are starting chemotherapy before surgery or other main cancer treatment (neoadjuvant).
- You are 18 or older, and you can read and sign a consent form in English or Spanish.
- You can get your doctor’s approval to do moderate exercise and you don’t have joint, breathing, heart, or muscle problems that stop it.
- You currently do 60 minutes or less per week of structured exercise, and you do not smoke (no smoking in the last 12 months).
- You can travel to Dana-Farber Cancer Institute for study visits and safety check-ins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a home-based exercise and nutrition program can help people with pancreatic cancer get stronger before surgery. It’s designed for those who are not already doing regular strength training.
This study tests whether a strength-training exercise program (focusing on muscle building) can help increase muscle mass and improve quality of life for people with advanced pancreatic cancer that cannot be surgically removed. Participants will follow a guided resistance training program while undergoing chemotherapy or immunotherapy.
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
This study tests whether adding a diabetes treatment to standard chemotherapy helps people with pancreatic cancer that has spread and who also have diabetes. It might improve how well the cancer is controlled and how you feel.
This trial tests a new immunotherapy drug called ivonescimab combined with chemotherapy, with or without another experimental drug (AK117), for people with pancreatic cancer that has spread. The goal is to see if adding these therapies can help shrink tumors or slow the cancer's growth.
This study tests whether adding Baduanjin, a traditional Chinese mind-body exercise, to standard chemotherapy can improve quality of life for people with pancreatic cancer. Participants will practice Baduanjin while continuing their usual NALIRIFOX chemotherapy.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.